Michael J. Ostacher, MD, MPH
Dr. Ostacher’s main research interests are bipolar disorder and comorbid substance use disorders. His projects have included the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder, a study of caregiver burden in bipolar disorder and BALANCE, a multinational study of maintenance treatments for bipolar disorder. Dr. Ostacher is co-PI for the U.S. arm of BALANCE.
- Associate Medical Director, Bipolar and Research Program, Massachusetts General Hospital Instructor in Psychiatry, Harvard Medical School
- MD, Vanderbilt University School of Medicine MPH, Harvard University School of Public Health, Health Care Management
- Ostacher MJ. Comorbid alcohol and substance abuse dependence in depression: Impact on the outcome of antidepressant treatment. Psychiatr Clin North Am. 2007;30:69—76.
- Simon, NM, Pollack, MH, Ostacher, MJ, et al. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007;97:91—99.
- Maytal G, Ostacher M, Stern TA. Aripiprazole-related tardive dyskinesia. CNS Spectrums, 2006;11:435—439.
- Nierenberg AA, Ostacher MJ, Calabrese JR, et al. Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006;163:210—216.
- Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;163:217—224.
- Attending a Career Development Institute
- Between Papers & Patients
- How Do the Meds Actually Work?
- Returning to Research
- Transition from Boss to Beginner